Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
McKinsey
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 8,840,887

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,840,887
Title:Antibodies
Abstract: The present invention relates to the use of VEGF antagonists and a novel anti-.alpha.5.beta.1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-.alpha.5.beta.1 antibodies and methods of making and using them.
Inventor(s): Liang; Wei-Ching (Foster City, CA), Plowman; Gregory D. (San Carlos, CA), Wu; Yan (Foster City, CA), Ye; Weilan (Foster City, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Application Number:13/112,839
Patent Claims:see list of patent claims

Details for Patent 8,840,887

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. AVASTIN bevacizumab Injection 125085 2004-02-26 ⤷  Free Forever Trial 2027-09-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKesson
Medtronic
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.